PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO EVALUATE THE SYSTEMIC EXPOSURE OF GEFITINIB IN THE CYP2D6 ULTRARAPID METABOLIZERS AND EXTENSIVE METABOLIZERS.

被引：0
|
作者：
Chen, Y. [1 ]
Zhou, W. [1 ]
Tang, W. [1 ]
Zhou, D. [1 ]
Masson, E. [1 ]
机构：
[1] Astrazeneca, Waltham, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-021
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [1] Physiologically Based Pharmacokinetic Modeling to Evaluate the Systemic Exposure of Gefitinib in CYP2D6 Ultrarapid Metabolizers and Extensive Metabolizers
    Chen, Yingxue
    Zhou, Diansong
    Tang, Weifeng
    Zhou, Wangda
    Al-Huniti, Nidal
    Masson, Eric
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (04): : 485 - 493
  • [2] Pharmacokinetic disposition of nebivolol in extensive and poor CYP2D6 metabolizers.
    Shaw, AA
    Ziemniak, J
    Liu, S
    Chervenick, SW
    Rackley, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P77 - P77
  • [3] Lack of effect of aprepitant on the pharmacokinetics of hydrodolasetron in CYP2D6 extensive and poor metabolizers.
    Li, X
    Pequignot, E
    Panebianco, D
    Majumdar, A
    Selverian, D
    Rosen, L
    Petty, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P47 - P47
  • [4] Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers
    Güzey, C
    Spigset, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) : 211 - 212
  • [5] Pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Pedersen, RS
    Damkier, P
    Brosen, K
    DRUG METABOLISM REVIEWS, 2005, 37 : 63 - 64
  • [6] Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
    de Leon, J
    Dinsmore, L
    Wedlund, P
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) : 420 - 421
  • [7] Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations
    Elmokadem, Ahmed
    Bruno, Christopher D.
    Housand, Conrad
    Jordie, Eric Burroughs
    Chow, Christina R.
    Lesko, Lawrence J.
    Greenblatt, David J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (01): : 66 - 75
  • [8] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Pedersen, Rasmus Steen
    Damkier, Per
    Brosen, Kim
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 513 - 521
  • [9] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Rasmus Steen Pedersen
    Per Damkier
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2006, 62 : 513 - 521
  • [10] Primary bioavailability parameters of loratadine in CYP2D6 extensive metabolizers
    Kunicki, PK
    Gutkowski, P
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 525 - 525
12345